[Federal Register: June 27, 2002 (Volume 67, Number 124)]
[Notices]               
[Page 43342-43343]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27jn02-110]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division

 
Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Chemical, Biological and Radiological 
Technology Alliance (``CBRTA'')

    Notice is hereby given that, on May 29, 2002, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), 3M Company (``3M'') has filed 
written notifications simultaneously with the Attorney General and the 
Federal Trade Commission disclosing (1) the identities of the parties 
and (2) the nature and objectives of the venture. The notifications 
were filed for the purpose of invoking the Act's provisions limiting 
the recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Pursuant to section 6(b) of the Act, the identities of 
the parties are 3M Company, St. Paul, MN; Becton Dickinson and Company, 
acting through its BD Biosciences Business Unit, Franklin Lakes, NJ; BV 
Solutions Group, Inc., Overland Park, KS; Calspan-UB Research Center, 
Buffalo, NY; Cargill Incorporated, Wayzata, MN; General Dynamics 
Government Systems Corporation, Thousand Oaks, CA; Honeywell 
International Inc., Minneapolis, MN; Johns Hopkins University Applied 
Physics Laboratory, Laurel, MD; Lucent Technologies Inc., McLeansville, 
NY; Mayo Clinic Rochester, Rochester, NY; Motorola, Schaumburg, IL; 
RAE, Inc., Arlington, VA; Syracuse Research Corporation, Syracuse, NY; 
and Veridian Corporation, Arlington, VA. The fourteen parties formed a 
consortium called the ``Chemical, Biological, and Radiological 
Technology Alliance'' (``CBRTA''). The purpose of the CBRTA is to 
develop technologies that will provide detection, identification, and 
warning systems for defense against chemical, biological, and 
radiological

[[Page 43343]]

attacks. The CBRTA is performing the technology development under 
Government R&D Contract No. NMA401-02-9-2002, awarded by the U.S. 
Department of Defense's National Imagery and Mapping Agency (NIMA) to 
the CBRTA.

Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 02-16221 Filed 6-26-02; 8:45 am]
BILLING CODE 4410-11-M